Study finds vitamin D supplements with or without Omega-3s decreased risk of autoimmune diseases
Brigham and Women’s Hospital, January 27 2022
Autoimmune diseases (AD) such as rheumatoid arthritis, polymyalgia rheumatica, autoimmune thyroid disease and psoriasis, are a leading cause of morbidity and mortality as people age. Few effective treatments are available for AD, but some preclinical studies have hinted that supplements, including vitamin D and omega-3 (or n-3) fatty acids, may hav...
Study finds vitamin D supplements with or without Omega-3s decreased risk of autoimmune diseases
Brigham and Women’s Hospital, January 27 2022
Autoimmune diseases (AD) such as rheumatoid arthritis, polymyalgia rheumatica, autoimmune thyroid disease and psoriasis, are a leading cause of morbidity and mortality as people age. Few effective treatments are available for AD, but some preclinical studies have hinted that supplements, including vitamin D and omega-3 (or n-3) fatty acids, may have beneficial effects. In a new study published in BMJ, investigators from Brigham and Women’s Hospital evaluated whether taking vitamin D and/or omega fatty acid supplements could affect rates of AD. The team tested this in the large-scale vitamin D and Omega-3 Trial (VITAL), a randomized study which followed participants for approximately five years. Investigators found the people who took vitamin D, or vitamin D and omega-3 fatty acids had a significantly lower rate of AD than people who took a placebo.
(NEXT)
Blueberry extract outperforms radiation in killing cervical cancer cells, study reveals
University of Missouri, January 27, 2022
Recent research has focused on attempts to identify radiosensitizers – or non-toxic, natural substances that can make radiation more effective – and (you guessed it) blueberry extract is emerging at the forefront – with a new study showcasing its ability to work along with radiation to combat cervical cancer. In a study of human cancer cells conducted at the University of Missouri, researchers found that combining blueberry extract with radiation increased the treatment’s effectiveness.
(NEXT)
Physical activity protects against type 2 diabetes by modifying metabolism
University of Eastern Finland, January 26, 2022
Regular physical activity significantly changes the body’s metabolite profile, and many of these changes are associated with a lower risk of type 2 diabetes, a new study from the University of Eastern Finland shows. The study population included more than 7,000 men who were followed up for eight years. Men in the highest physical activity category had a 39% lower risk of type 2 diabetes than men who were physically inactive. Physical activity was associated with the levels of a total of 198 metabolites, i.e., compounds formed as a result of the body’s metabolism, and increased physical activity had an impact on some of the same metabolites that have previously been associated with a health-promoting diet. In addition, the study showed that increased physical activity improves insulin secretion.
(NEXT)
Food as medicine
Mayo Clinic, January 26 2022.
The oft-heard adage “Let food be thy medicine” appears to be valid advice according to the results of a first of its kind study published on January 26, 2022 in the Journal of Nutrition. “Based on the outcomes seen in our study, using this type of food as medicine approach expands the options for medical professionals and patients,” first author Stephen Kopecky, MD, FACC, of the Mayo Clinic commented. “Many patients who are unwilling or unable to take statin drugs may be able to help manage their high cholesterol, or hyperlipidemia with a realistic food-based intervention.”
(NEXT)
Maternal consumption of soft drinks may be linked to ADHD symptoms in offspring
University of Bergen (Norway), January 27, 2022
Norwegian, Swedish and Dutch researchers examining a large Norwegian population-based cohort recently reported in European Journal of Nutrition that daily maternal intake of sweetened carbonated beverages (SCB) in pregnancy was associated with an increase in ADHD symptoms among offspring at eight years of age.
(VIDEO)
1. Barrister Una McGurk (Ireland) on pandemic and cancel culture – 6 minutes
2. VOICES PROFESSOR DOLORES CAHILL (2:56)
3. VOICES: ANNE MCCLOSKEY GP (3:48)
4. VOICES: DR PAT MORRISSEY (5:02)
5. VOICES: DR MARCUS DE BRUN (5:13)
(OTHER NEWS)
How 5G Puts Airplanes at Risk – An Electrical Engineer Explains
By Prasenjit Mitra, Professor of Information Sciences and Technology, Penn State. The Conversation, January 26, 2022
New high-speed cellphone services have raised concerns of interference with aircraft operations, particularly as aircraft are landing at airports. The Federal Aviation Administration has assured Americans that most commercial aircraft are safe, and AT&T and Verizon have agreed to hold off on installing their new cellphone antennas near airports for six months. But the problem has not been entirely resolved.
Concerns began when the U.S. government auctioned part of the C-band spectrum to wireless carriers in 2021 for US$81 billion. The carriers are using C-band spectrum to provide 5G service at full speed, 10 times the speed of 4G networks. The C-band spectrum is close to the frequencies used by key electronics that aircraft rely on to land safely. Here’s why that can be a problem.
Wireless signals are carried by radio waves. The radio spectrum ranges from 3 hertz to 3,000 gigahertz and is part of the electromagnetic spectrum. The portion of the radio spectrum that carries the signals from your phone and other wireless devices is 20 kilohertz to 300 gigahertz.
If two wireless signals in the same area use the same frequency, you get garbled noise.
Modern airplanes use altimeters, which calculate the time it takes for a signal to bounce back from the ground to determine a plane’s altitude. These altimeters are a vital part of automatic landing systems that are especially useful in cases where there is low visibility.
So, if an altimeter interprets a signal from a wireless carrier as the rebounded signal from the ground, it may think that the ground is closer than it is and prematurely try to lower the landing gear and do the other maneuvers that are needed to land an aircraft. If interference with wireless carrier signals corrupts and garbles the altimeter’s radio signals, the altimeter may not recognize the rebounded signal and thus be unable to figure out how close to the ground the plane is.
The portions of the radio frequency spectrum used by airplanes and cellphone carriers are different. The problem is that airplane altimeters use the 4.2 to 4.4 gigahertz range, while the recently sold – and previously unused – C-band spectrum for wireless carriers ranges from 3.7 to 3.98 gigahertz. It turns out the 0.22 gigahertz difference between the signals may not be quite enough to be absolutely sure that a cellphone carrier signal will not be mistaken for or corrupt an altimeter’s signal.
(NEXT)
The Scientific Misconduct Story Behind Ivermectin
Joseph Mercola, January 26, 2022
STORY AT-A-GLANCE In mid-February 2021, Dr. Andrew Hill at Liverpool University published a scientific meta-analysis of six randomized controlled trials involving the use of ivermectin. The review, funded by the World Health Organization and UNITAID, found the drug increased viral clearance and reduced COVID-19 deaths by 75%, yet the conclusion of the paper was dismissive In early April 2021, Hill was accused of scientific misconduct by the French civic group, Association BonSens. BonSens claims Hill manipulated data to downplay the usefulness of ivermectin. Hill admitted that the study sponsor had crafted the conclusion In early August 2021, Hill published a public notice stating one of the six studies included in his analysis had been withdrawn due to fraudulent data. A revised analysis excluding that study was published in November 2021 In the November revision, Hill included 23 randomized clinical trials, concluding ivermectin had no statistically significant effect on survival or hospitalizations Other meta-analyses of 13 to 24 studies have found reductions in death ranging from 62% to 91%. Recent research has also found a five-day course of ivermectin at a dose of 12 mg per day sped up viral clearance, reducing the duration of symptomatic illness by three days compared to placebo (9.7 days versus 12.7 days)
